1. Home
  2. VACH
  3. VACH News

Latest VOYAGER ACQUISITION CORP. (VACH) News on June 5, 2025

Ulta Stock Jumps as Beauty Product Spending Continues
VACH

Investopedia

6 days ago

Ulta Stock Jumps as Beauty Product Spending Continues

Drone Light Show Market to Soar to $5 Billion by 2034, Fueled by 13% CAGR and Rising Demand for Innovative Entertainment | Exactitude Consultancy
VACH

GlobeNewswire

6 days ago

Drone Light Show Market to Soar to $5 Billion by 2034, Fueled by 13% CAGR and Rising Demand for Innovative Entertainment | Exactitude Consultancy

Silicon Photonics Market Set to Surge to USD 13.9 Billion by 2034, Driven by 12.5% CAGR | Exactitude Consultancy
VACH

GlobeNewswire

6 days ago

Silicon Photonics Market Set to Surge to USD 13.9 Billion by 2034, Driven by 12.5% CAGR | Exactitude Consultancy

Northrop Grumman Raises $1 Billion Via Debt
VACH

Benzinga

6 days ago

Northrop Grumman Raises $1 Billion Via Debt

Spinosad Active Ingredient Market Set for Steady Growth, Driven by Sustainable Farming Trends | Exactitude Consultancy
VACH

GlobeNewswire

6 days ago

Spinosad Active Ingredient Market Set for Steady Growth, Driven by Sustainable Farming Trends | Exactitude Consultancy

The York Water Company Files a Rate Request Based on $145 Million in Investment
VACH

GlobeNewswire

6 days ago

The York Water Company Files a Rate Request Based on $145 Million in Investment

VACH

Newsfile

6 days ago

Max Resource Corp. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

TEN, Ltd. Announces Date for the First Quarter 2025 Results, Conference Call and Webcast
VACH

GlobeNewswire

6 days ago

TEN, Ltd. Announces Date for the First Quarter 2025 Results, Conference Call and Webcast

VACH

GlobeNewswire

7 days ago

VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer
VACH

GlobeNewswire

16 days ago

VERAXA Biotech Appoints Rick Austin as Chief Scientific Officer

VACH

MT Newswires

a month ago

OmniAb, Veraxa Biotech Partner on Solid Tumor Drug Discovery Program

VACH

GlobeNewswire

a month ago

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

Veraxa to go public in $1.6bn SPAC deal with Voyager
VACH

Pharmaceutical Technology

a month ago

Veraxa to go public in $1.6bn SPAC deal with Voyager

VACH

MT Newswires

a month ago

Voyager Acquisition, VERAXA Biotech to Merge, Creating $1.64 Billion Public Cancer Therapy Company

VACH

GlobeNewswire

a month ago

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

Share on Social Networks: